ID   D5K9S7_HUMAN            Unreviewed;       186 AA.
AC   D5K9S7;
DT   15-JUN-2010, integrated into UniProtKB/TrEMBL.
DT   15-JUN-2010, sequence version 1.
DT   27-MAR-2024, entry version 72.
DE   SubName: Full=POU domain transcription factor OCT4-pg3 {ECO:0000313|EMBL:ADE48564.1};
GN   Name=POU5F1P3 {ECO:0000313|EMBL:ADE48564.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADE48564.1};
RN   [1] {ECO:0000313|EMBL:ADE48564.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Breast carcinoma {ECO:0000313|EMBL:ADE48605.1}, and Glioma
RC   {ECO:0000313|EMBL:ADE48590.1};
RA   Zhao S., Yuan Q., Liu S., Zhang Y., Liu H., Wang F., Liu K., Hao A.;
RT   "Expression of OCT4 Pseudogenes in Human Somatic Tumors.";
RL   Submitted (JAN-2010) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:ADW77361.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Breast cancer luminal A subtype {ECO:0000313|EMBL:ADW77456.1},
RC   Glioma WHO grade II {ECO:0000313|EMBL:ADW77361.1}, Glioma WHO grade
RC   III {ECO:0000313|EMBL:ADW77389.1}, and Glioma WHO grade IV
RC   {ECO:0000313|EMBL:ADW77425.1};
RA   Zhao S., Yuan Q., Guo Y., Liu S., Zhang Y., Wang J., Liu H., Wang F.,
RA   Liu K., Ling E.-A., Hao A.;
RT   "Expression of OCT4 pseudogenes in two human somatic tumours: glioma and
RT   breast carcinoma.";
RL   Submitted (AUG-2010) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GU480838; ADE48564.1; -; mRNA.
DR   EMBL; GU480876; ADE48590.1; -; mRNA.
DR   EMBL; GU480887; ADE48598.1; -; mRNA.
DR   EMBL; GU480892; ADE48600.1; -; mRNA.
DR   EMBL; GU480897; ADE48605.1; -; mRNA.
DR   EMBL; GU480907; ADE48611.1; -; mRNA.
DR   EMBL; HQ122722; ADW77361.1; -; mRNA.
DR   EMBL; HQ122724; ADW77363.1; -; mRNA.
DR   EMBL; HQ122725; ADW77364.1; -; mRNA.
DR   EMBL; HQ122726; ADW77365.1; -; mRNA.
DR   EMBL; HQ122728; ADW77367.1; -; mRNA.
DR   EMBL; HQ122729; ADW77368.1; -; mRNA.
DR   EMBL; HQ122730; ADW77369.1; -; mRNA.
DR   EMBL; HQ122753; ADW77389.1; -; mRNA.
DR   EMBL; HQ122754; ADW77390.1; -; mRNA.
DR   EMBL; HQ122791; ADW77425.1; -; mRNA.
DR   EMBL; HQ122792; ADW77426.1; -; mRNA.
DR   EMBL; HQ122793; ADW77427.1; -; mRNA.
DR   EMBL; HQ122794; ADW77428.1; -; mRNA.
DR   EMBL; HQ122795; ADW77429.1; -; mRNA.
DR   EMBL; HQ122796; ADW77430.1; -; mRNA.
DR   EMBL; HQ122828; ADW77456.1; -; mRNA.
DR   EMBL; HQ122829; ADW77457.1; -; mRNA.
DR   EMBL; HQ122831; ADW77459.1; -; mRNA.
DR   AlphaFoldDB; D5K9S7; -.
DR   PeptideAtlas; D5K9S7; -.
DR   AGR; HGNC:9222; -.
DR   GeneCards; POU5F1P3; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   Gene3D; 1.10.260.40; lambda repressor-like DNA-binding domains; 1.
DR   InterPro; IPR010982; Lambda_DNA-bd_dom_sf.
DR   InterPro; IPR000327; POU_dom.
DR   Pfam; PF00157; Pou; 1.
DR   SUPFAM; SSF47413; lambda repressor-like DNA-binding domains; 1.
DR   PROSITE; PS51179; POU_3; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          138..186
FT                   /note="POU-specific"
FT                   /evidence="ECO:0000259|PROSITE:PS51179"
FT   REGION          1..59
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          86..118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          167..186
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   186 AA;  19206 MW;  A1A8E955E7A26AEC CRC64;
     MAGHLASDFA FSPPPGGGGD GPGGPEPGWV DPRTWLSFQG PPGGPGIGPG FGPGSEEWGI
     PPCPPPYEFC GGMAYCGPQT GVGLVPQDGL ETSQPEGEAG VGVESNSDGA SPEPCTVPSG
     AVKLEKEKLE QNPKESQDIK ALQKELEQFA KLLKQKRITL GYTQADVAHP GGSIWEGVQP
     NDHLPL
//